All Comments by Nikolaos K. Robakis
- Peter Davies, Beloved Giant of Alzheimer’s Disease Research, Dies at 72
- Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis.
- Evidence for lymphatic Aβ clearance in Alzheimer's transgenic mice.
- Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP.
- Testing the right target and right drug at the right stage.
- Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer model.
- Higher incidence of mild cognitive impairment in familial hypercholesterolemia.
- γ-Secretase Drives Spine Formation Via Novel Substrate
- Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2.
- Presenilin Loss of Function—Plan B for AD?
- Protease or Not?—More to Presenilin Toxicity than Meets the (Fly's) Eye
- Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology.
- Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
- Dangerous Liaisons—Tau and Aβ, Together at Last?